The average price target represents 80.60% Increase from the current price of $10. Trulieve Cannabis's analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
The average one-year price target for Trulieve Cannabis Corp. is $18.13. The forecasts range from a low of $14.24 to a high of $29.60. A stock's price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.
The Trulieve Cannabis Corp stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock.
Trulieve achieved a gross margin of 58%, translating to a gross profit of $174 million, up from $150 million in the same quarter of the previous year. The company's net loss improved significantly to $23 million, a 31% sequential improvement and a 64% improvement year-over-year.
The $2.1 billion acquisition of Harvest Health & Recreation by Florida cannabis behemoth Trulieve Cannabis Corp. has finally been consummated, creating the largest marijuana company in the U.S., with a combined 149 dispensaries and operations in 11 states.
Approximately 13.33% of the company's stock is owned by Institutional Investors, 25.96% is owned by Insiders and 60.71% is owned by Public Companies and Individual Investors.
Based on analyst ratings, Curaleaf Holdings's 12-month average price target is $6.05. Curaleaf Holdings has 113.03% upside potential, based on the analysts' average price target. Curaleaf Holdings has a consensus rating of Strong Buy which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
Introduction: My name is Trent Wehner, I am a talented, brainy, zealous, light, funny, gleaming, attractive person who loves writing and wants to share my knowledge and understanding with you.
We notice you're using an ad blocker
Without advertising income, we can't keep making this site awesome for you.